全球代谢体学市场规模、份额、趋势和成长分析报告（2026-2034）

预计代谢体学市场将从 2025 年的 39.2 亿美元成长到 2034 年的 112.9 亿美元，2026 年至 2034 年的复合年增长率为 12.46%。

由于人们对个人化医疗和疾病研究的兴趣日益浓厚，全球代谢体学市场正经历快速增长。代谢体学研究生物系统中的小分子，有助于科学家了解疾病机制并识别生物标记。对药物研发和生物技术投入的增加正在推动对代谢体学技术的需求。

此外，质谱和核磁共振（NMS）技术的进步正在推动市场发展。这些工具能够对复杂的生物样本进行精确分析，从而支持药物研发和临床诊断。随着人们对疾病早期检测和精准医疗的日益关注，代谢体学在研究和医疗机构中的应用正在加速成长。

展望未来，人工智慧（AI）与巨量资料分析的融合有望提升数据解读与研究成果。代谢组学在营养学、毒理学和环境研究等领域的应用拓展将进一步扩大市场规模。随着技术的持续创新和医疗保健投资的不断增长，预计代谢体学市场在未来几年将保持强劲成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球代谢体学市场：依产品与服务划分

• 市场分析、洞察与预测
• 代谢体学学设备
• 代谢体学和生物资讯学工具及服务

第五章：全球代谢体学市场：依应用划分

• 市场分析、洞察与预测
• 生物标记发现
• 药物发现
• 毒性测试
• 营养基因体学
• 功能基因体学
• 个人化医疗
• 其他用途

第六章：全球代谢体学市场：依适应症划分

• 市场分析、洞察与预测
• 癌症
• 心血管疾病
• 神经系统疾病
• 先天性代谢缺陷
• 其他迹象

第七章 全球代谢体学市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Biocrates Life Sciences AG
  • Shimadzu Corporation
  • Bio-Rad Laboratories Inc
  • Waters Corporation
  • Danaher Corporation
  • Bruker Corporation
  • LECO Corporation
  • Agilent Technologies Inc
  • Human Metabolome Technologies Inc
  • Metabolon Inc

The Metabolomics Market size is expected to reach USD 11.29 Billion in 2034 from USD 3.92 Billion (2025) growing at a CAGR of 12.46% during 2026-2034.

The Global Metabolomics Market is witnessing rapid growth due to rising interest in personalized medicine and advanced disease research. Metabolomics studies small molecules in biological systems, helping scientists understand disease mechanisms and identify biomarkers. Increasing investments in pharmaceutical research and biotechnology are fueling demand for metabolomics technologies.

The market is also driven by technological advancements in mass spectrometry and nuclear magnetic resonance techniques. These tools enable accurate analysis of complex biological samples, supporting drug discovery and clinical diagnostics. Growing focus on early disease detection and precision healthcare is encouraging the use of metabolomics in research laboratories and healthcare institutions.

Looking ahead, integration of artificial intelligence and big data analytics is expected to enhance data interpretation and research outcomes. Expanding applications in nutrition, toxicology, and environmental studies will further broaden market scope. With continuous innovation and rising healthcare investments, the metabolomics market is expected to maintain strong growth momentum in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Services

• Metabolomics Instruments
• Metabolomics Bioinformatics Tools and Services

By Application

• Biomarker Discovery
• Drug Discovery
• Toxicology Testing
• Nutrigenomics
• Functional Genomics
• Personalized Medicine
• Other Applications

By Indication

• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Inborn Errors of Metabolism
• Other Indications

COMPANIES PROFILED

• Biocrates Life Sciences AG, Shimadzu Corporation, BioRad Laboratories Inc, Waters Corporation, Danaher Corporation, Bruker Corporation, LECO Corporation, Agilent Technologies Inc, Human Metabolome Technologies Inc, Metabolon Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL METABOLOMICS MARKET: BY PRODUCT AND SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Services
• 4.2. Metabolomics Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Metabolomics Bioinformatics Tools and Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL METABOLOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Biomarker Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Toxicology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nutrigenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Functional Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Personalized Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL METABOLOMICS MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Inborn Errors of Metabolism Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL METABOLOMICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product And Services
  • 7.2.2 By Application
  • 7.2.3 By Indication
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product And Services
  • 7.3.2 By Application
  • 7.3.3 By Indication
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product And Services
  • 7.4.2 By Application
  • 7.4.3 By Indication
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product And Services
  • 7.5.2 By Application
  • 7.5.3 By Indication
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product And Services
  • 7.6.2 By Application
  • 7.6.3 By Indication
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL METABOLOMICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Biocrates Life Sciences AG
  • 9.2.2 Shimadzu Corporation
  • 9.2.3 Bio-Rad Laboratories Inc
  • 9.2.4 Waters Corporation
  • 9.2.5 Danaher Corporation
  • 9.2.6 Bruker Corporation
  • 9.2.7 LECO Corporation
  • 9.2.8 Agilent Technologies Inc
  • 9.2.9 Human Metabolome Technologies Inc
  • 9.2.10 Metabolon Inc